世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医薬品ろ過市場：製品（メンブレン、デプスフィルター）、システム（シングルユース、リユーザブル）、技術（精密ろ過、ナノろ過）、用途（原薬、ワクチン、抗体）、運用規模（製造、パイロット、研究開発）、地域別 - 2028年までの世界予測


Pharmaceutical Filtration Market by Product (Membrane, Depth filter), System (Single use, Reusable), Technique (Microfiltration, Nanofiltration), Application (API, Vaccine, Antibody), Scale of Operation (Manufacturing, Pilot, R&D) & Region - Global Forecasts to 2028

医薬品用フィルター市場は、予測期間中に14.2%のCAGRで成長すると予想されています。2023年の市場規模は約135億米ドルと推定され、2028年には262億米ドルに達すると予測されています。医薬品ろ過市場の成長は、中... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年2月13日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		433 563 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

医薬品用フィルター市場は、予測期間中に14.2%のCAGRで成長すると予想されています。2023年の市場規模は約135億米ドルと推定され、2028年には262億米ドルに達すると予測されています。医薬品ろ過市場の成長は、中国、インド、ブラジル、メキシコなどの新興国が大きな成長機会を提供していること、ナノファイバー技術の進歩、医薬品・バイオテクノロジー産業における製造や研究開発の増加などの要因に起因しています。一方、膜の汚損や新しい生産設備の設置に必要な設備投資の増大は、市場成長の妨げになると予想されます。
"2022年、システム部門は医薬品市場で2番目のシェアを占める"
製薬用ろ過市場は、製品に基づき、フィルター、システム、その他の製品の大きく3つのセグメントに分類されます。フィルター市場は、メンブレンフィルター、デプスフィルター、プレフィルター、バッグフィルター、マグネットフィルターなどのその他のフィルターにさらに細分化されます。システム市場は、さらにシングルユースシステムとリユースシステムに区分される。2022年、システム部門は医薬品市場で2番目に大きなシェアを占めています。このセグメントの大きなシェアは、主に分離・精製アプリケーションの重要性が高まっていることに起因しています。研究技術の発展やろ過プロセスにおける特異性への要求の高まりにより、多くの小規模なバイオ医薬品プロセスにおいてシングルユース技術の採用が進んでいます。
"限外ろ過技術は、2022年にこの市場の2番目の市場シェアを占めた"
技術に基づき、医薬用ろ過市場は精密ろ過、限外ろ過、ナノろ過、その他の技術に区分されます。その他の技法には、逆浸透とイオン交換が含まれます。精密ろ過技術は、2022年にこの市場の2番目に大きな市場シェアを占め、これは主に細胞採取と酵素精製血漿分離のための限外ろ過の実施に起因すると考えられます。また、医薬品有効成分、培地・緩衝液、製剤、充填液のろ過にも使用されています。精密ろ過では不可能なウイルス、ファージ、コロイド、高分子の除去が可能であるため、市場で大きなシェアを獲得しています。
"2022年、無菌ろ過技術が本市場の最大シェアを占めた"
タイプに基づき、医薬品ろ過市場は無菌ろ過と非無菌ろ過に区分されます。2022年の本市場では、無菌ろ過技術が最大の市場シェアを占めており、これは、生物製剤の急成長、生物製剤の液体処理時の無菌ろ過の要件の急増、無菌ろ過の非無菌ろ過に対する利点などの要因によるものと考えられる。
Merck KGaA（ドイツ）、Danaher Corporation（米国）、Sartorius AG（ドイツ）、Parker-Hannifin Corporation（米国）、Thermo Fisher Scientific Inc（米国）、3M Company（米国）、Eaton Corporation plc（米国）、Donaldson Company, Inc（米国）、Repligen Corporation（米国）、Porvair plc（英国）、Alfa Laval Corporate AB（スウェーデン）、Corning Incorporated（米国）、Meissner Filtration Products, Inc（米国）、Amazon Filters Ltd.(英国)、Graver Technologies, LLC(米国)、MMS AG(スイス)、MANN+HUMMEL International GmbH & Co.KG（ドイツ）、ErtelAlsop（米国）、Kasag Swiss AG（スイス）、Freudenberg Filtration Technologies SE & Co.KG（ドイツ）、Cole-Parmer Instrument Company, LLC.(米国）、Cantel Medical Corp.（米国）、Filtrox AG（スイス）、Saint-Gobain Performance Plastics（フランス）、Membrane Solutions（米国）などが、医薬品ろ過市場で事業を展開している主要企業です。

"アジア太平洋地域医薬品用フィルター市場で最も成長著しい地域"
医薬品用フィルター市場は、北米、欧州、アジア太平洋地域、中南米（LATAM）、中東・アフリカ（MEA）に区分されます。アジア太平洋地域は、ウイルス性疾患の発生率の増加、海外の厳しい規制ルールによるクリーンな製造環境の維持の必要性、ジェネリック医薬品製造の急速な拡大、ナノファイバー技術の開発、バイオ医薬品プロジェクトに対する研究開発費の増加、発展途上国におけるバイオテクノロジー産業の成長などにより、市場で最も急速に成長しているセグメントと推定されます。
本レポートのために実施した一次インタビューは、以下のように分類されます：

- 回答者別供給側：80％、需要側：20
- 役職別マネージャー45％、CXO・ディレクタークラス30％、エグゼクティブ25％。
- 地域別北米：20％、欧州：10％、アジア太平洋：55％、RoW：15％。
レポート掲載企業一覧
- メルクKGaA（ドイツ）
- ダナハーコーポレーション（米国）
- ザルトリウスAG（ドイツ）
- パーカー・ハニフィン・コーポレーション（米国）
- サーモフィッシャーサイエンティフィック社(米国)
- スリーエムカンパニー（米国）
- イートン・コーポレーション・ピーエルシー（米国）
- Donaldson Company, Inc（アメリカ）
- レプリジェンコーポレーション（米国）
- ポーヴェア・ピーエルシー（英国）
- Alfa Laval Corporate AB（スウェーデン）
- コーニング・インコーポレイテッド（米国）
- マイスナー・フィルトレーション・プロダクツ社（アメリカ）
- Amazon Filters Ltd.(イギリス)
- グラバー・テクノロジーズ・エルエルシー（米国）
- MMS AG（スイス）
- MANN+HUMMEL International GmbH & Co.KG (ドイツ)
- ErtelAlsop（米国）
- カサグ・スイスAG（スイス）
- フロイデンベルグ フィルトレーション テクノロジー SE & Co.KG（ドイツ）
- コール・パーマー・インストゥルメント・カンパニー・エルエルシー（Cole-Parmer Instrument Company, LLC.(米国)
- キャンテルメディカル社（米国）
- フィルトロックスAG（スイス）
- サンゴバン・パフォーマンス・プラスチックス（フランス）
- メンブレン・ソリューションズ（米国）
調査対象です：
本レポートは、医薬品用ろ過市場の詳細な情報を提供します。製品、用途、エンドユーザー、地域などの異なるセグメントにおける市場規模および今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要や最近の開発状況、主要な市場戦略とともに、詳細な競合分析も行っています。

レポートを購入する主な利点
本レポートは、医薬品ろ過市場全体とそのサブセグメントに関する収益数の最も近い近似値を提供することで、市場リーダー/新規参入者の助けとなります。また、利害関係者が競争環境をよりよく理解し、より多くの洞察を得ることで、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるのに役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、トレンド、機会に関する情報を提供することを可能にします。

ページTOPに戻る


目次

1 INTRODUCTION 58
1.1 STUDY OBJECTIVES 58
1.2 MARKET DEFINITION 58
1.2.1 INCLUSIONS AND EXCLUSIONS 59
1.3 MARKET SCOPE 60
1.3.1 MARKETS COVERED 60
1.3.2 YEARS CONSIDERED 61
1.4 CURRENCY CONSIDERED 61
1.5 LIMITATIONS 61
1.6 STAKEHOLDERS 62
1.7 SUMMARY OF CHANGES 62
1.7.1 RECESSION IMPACT 63
2 RESEARCH METHODOLOGY 64
2.1 RESEARCH DATA 64
FIGURE 1 RESEARCH DESIGN 64
2.1.1 SECONDARY DATA 65
2.1.2 PRIMARY DATA 66
FIGURE 2 BREAKDOWN OF PRIMARIES, BY RESPONDENT, DESIGNATION, AND REGION 66
2.2 MARKET ESTIMATION METHODOLOGY 67
FIGURE 3 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 67
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 68
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 69
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 69
2.3 MARKET GROWTH RATE PROJECTIONS 70
FIGURE 6 PHARMACEUTICAL FILTRATION MARKET (SUPPLY SIDE): CAGR PROJECTIONS 71
FIGURE 7 PHARMACEUTICAL FILTRATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 72
2.3.1 DATA TRIANGULATION 73
FIGURE 8 DATA TRIANGULATION METHODOLOGY 73
2.4 RESEARCH ASSUMPTIONS 74
2.5 IMPACT OF RECESSION 74
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024−2027 (% GROWTH) 74
2.6 RISK ANALYSIS 75
 
3 EXECUTIVE SUMMARY 76
FIGURE 9 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 76
FIGURE 10 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 77
FIGURE 11 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 77
FIGURE 12 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 78
FIGURE 13 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023 VS. 2028 (USD MILLION) 79
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET 80
4 PREMIUM INSIGHTS 81
4.1 PHARMACEUTICAL FILTRATION MARKET OVERVIEW 81
FIGURE 15 INCREASING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH 81
4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT AND COUNTRY (2022) 82
FIGURE 16 FILTERS SEGMENT TO POSSESS LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL FILTRATION MARKET IN 2022 82
4.3 PHARMACEUTICAL FILTRATION MARKET SHARE, BY APPLICATION (2023 VS. 2028) 82
FIGURE 17 FINAL PRODUCT PROCESSING APPLICATIONS SEGMENT TO DOMINATE MARKET IN 2028 82
4.4 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022 (USD MILLION) 83
FIGURE 18 MICROFILTRATION SEGMENT TO DOMINATE MARKET, BY TECHNIQUE, IN 2022 83
4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 84
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028 84
5 MARKET OVERVIEW 85
5.1 INTRODUCTION 85
5.2 MARKET DYNAMICS 85
FIGURE 20 PHARMACEUTICAL FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 85
TABLE 2 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 86
5.2.1 DRIVERS 87
5.2.1.1 Growing biopharmaceutical industry 87
TABLE 3 INDICATIVE LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS, 2021 AND 2022 87
5.2.1.2 Rising R&D spending in pharmaceutical and biotechnology industries 88
FIGURE 21 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 88
5.2.1.3 Increasing adoption of single-use technologies 88
5.2.1.4 New product launches by leading market players 89
5.2.1.5 Increasing purity requirements in end-user segments 90
5.2.2 RESTRAINTS 90
5.2.2.1 Membrane fouling issues 90
5.2.2.2 Requirement of high capital investments for new production facilities 90
5.2.3 OPPORTUNITIES 91
5.2.3.1 Growth opportunities in emerging economies 91
5.2.3.2 Advances in nanofiber technology 91
5.2.4 CHALLENGES 92
5.2.4.1 Increased cost and reduced speed and yield of filters 92
5.2.4.2 Survival of small players and new entrants 92
5.3 RANGES/SCENARIOS 93
FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PHARMACEUTICAL FILTRATION MARKET 93
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PHARMACEUTICAL FILTRATION PRODUCT PROVIDERS 94
5.5 PRICING ANALYSIS 94
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS 94
TABLE 4 PRICE OF PHARMACEUTICAL FILTRATION PRODUCTS (2022) 94
5.5.2 AVERAGE SELLING PRICE TREND 94
5.6 VALUE CHAIN ANALYSIS 95
FIGURE 24 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET 96
5.7 SUPPLY CHAIN ANALYSIS 96
FIGURE 25 PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS 97
5.8 ECOSYSTEM ANALYSIS 98
FIGURE 26 ECOSYSTEM ANALYSIS: PHARMACEUTICAL FILTRATION MARKET 98
TABLE 5 SUPPLY CHAIN ECOSYSTEM 99
5.9 PATENT ANALYSIS 101
FIGURE 27 PATENT APPLICATIONS FOR PHARMACEUTICAL FILTRATION MARKET, JANUARY 2012–DECEMBER 2022 101
5.10 CASE STUDY ANALYSIS 101
5.10.1 IMPROVED CAPACITY AND EFFICIENCY OF CARBON REMOVAL PROCESS FROM ACTIVE PHARMACEUTICAL INGREDIENTS 101
5.10.2 FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID 102
5.10.3 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS 102
5.10.4 DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS 102
5.10.5 USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS 102
5.11 KEY CONFERENCES AND EVENTS IN 2023 103
TABLE 6 PHARMACEUTICAL FILTRATION MARKET: LIST OF CONFERENCES AND EVENTS 103
5.12 REGULATORY ANALYSIS 104
5.12.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 104
5.12.2 REGULATORY SCENARIO IN DIFFERENT REGIONS/COUNTRIES 105
5.13 PORTER’S FIVE FORCES ANALYSIS 106
TABLE 7 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 106
5.13.1 THREAT OF NEW ENTRANTS 106
5.13.2 THREAT OF SUBSTITUTES 107
5.13.3 BARGAINING POWER OF BUYERS 107
5.13.4 BARGAINING POWER OF SUPPLIERS 107
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 107
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.14.1 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND THEIR INFLUENCE ON BUYING PROCESS 108
FIGURE 28 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL COMPANIES ON BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS 108
5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS AMONG END USERS 108
FIGURE 29 KEY BUYING CRITERIA FOR END USERS 108
6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 109
6.1 INTRODUCTION 110
TABLE 8 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110
6.2 FILTERS 110
TABLE 9 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 10 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 11 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 12 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 13 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 14 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
6.2.1 MEMBRANE FILTERS 113
TABLE 15 GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 16 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 17 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 18 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 19 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 20 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 116
6.2.1.1 Polyethersulfone (PES) 116
TABLE 21 GLOBAL PES MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 22 NORTH AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 23 EUROPE: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 24 ASIA PACIFIC: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 25 LATIN AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.2.1.2 Polyvinylidene difluoride (PVDF) 119
6.2.1.2.1 FDA, USP, and EEC compliance to increase demand for PVDF filters 119
TABLE 26 GLOBAL PVDF MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 27 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 28 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 29 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 30 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
6.2.1.3 Nylon 121
6.2.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth 121
TABLE 31 GLOBAL NYLON MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 32 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 33 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 34 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 35 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.2.1.4 Polytetrafluoroethylene (PTFE) 123
6.2.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 123
TABLE 36 GLOBAL PTFE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 37 NORTH AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 38 EUROPE: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 39 ASIA PACIFIC: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 40 LATIN AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.2.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA) 125
6.2.1.5.1 MCE membranes widely used in analytical and research applications 125
TABLE 41 GLOBAL MCE & CA MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 42 NORTH AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 43 EUROPE: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 44 ASIA PACIFIC: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 45 LATIN AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.2.1.6 Polycarbonate track-etched (PCTE) 128
6.2.1.6.1 PCTE membrane filters widely used in cell biology and analytical testing applications 128
TABLE 46 GLOBAL PCTE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 47 NORTH AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 48 EUROPE: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 49 ASIA PACIFIC: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 50 LATIN AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
6.2.1.7 Other materials 130
TABLE 51 GLOBAL OTHER MATERIAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 52 NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 53 EUROPE: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 54 ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 55 LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
6.2.2 DEPTH FILTERS 133
TABLE 56 GLOBAL DEPTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 57 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 58 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 59 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 60 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 61 DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 135
6.2.2.1 Diatomaceous earth 136
6.2.2.1.1 DE filters used in biotechnology industry for cell clarification 136
TABLE 62 GLOBAL DIATOMACEOUS EARTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 63 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 64 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 65 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 66 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
6.2.2.2 Cellulose 138
6.2.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive growth 138
TABLE 67 GLOBAL CELLULOSE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 68 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 69 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 70 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 71 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
6.2.2.3 Activated carbon 140
6.2.2.3.1 Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations 140
TABLE 72 GLOBAL ACTIVATED CARBON FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 73 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 74 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 75 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 76 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
6.2.2.4 Perlite 143
6.2.2.4.1 Lower density of perlite provides more purity than diatomaceous earth 143
TABLE 77 GLOBAL PERLITE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 78 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 79 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 80 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 81 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
6.2.2.5 Other depth filter media 145
TABLE 82 GLOBAL OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 83 NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 84 EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 85 ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 86 LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
6.2.3 OTHER FILTERS 147
TABLE 87 GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 88 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 89 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 90 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 91 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
6.3 SYSTEMS 150
TABLE 92 GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 93 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 94 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 95 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 96 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 97 GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
6.3.1 SINGLE-USE SYSTEMS 153
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 153
TABLE 98 GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 99 NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 100 EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 101 ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 102 LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
6.3.2 REUSABLE SYSTEMS 155
6.3.2.1 Reusable systems widely used for large-scale manufacturing 155
TABLE 103 GLOBAL REUSABLE SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 155
TABLE 104 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 105 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 106 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 107 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
6.4 OTHER FILTRATION PRODUCTS 157
TABLE 108 OTHER FILTRATION PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 109 NORTH AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 110 EUROPE: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 111 ASIA PACIFIC: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 112 LATIN AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 113 OTHER FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
6.4.1 FILTRATION ASSEMBLIES 160
6.4.1.1 Leading players provide pre-assembled filtration assemblies 160
TABLE 114 GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION, 2021–2028 (USD MILLION) 161
TABLE 115 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 116 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 117 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 118 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
6.4.2 FILTER HOLDERS 163
6.4.2.1 Filter holders provide structural support to membrane filters 163
TABLE 119 GLOBAL FILTER HOLDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 120 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 121 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 122 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 123 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 165
6.4.3 FILTRATION ACCESSORIES 165
6.4.3.1 Increasing adoption of pharmaceutical filtration products to support growth 165
TABLE 124 GLOBAL PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 125 NORTH AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 126 EUROPE: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 127 ASIA PACIFIC: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 128 LATIN AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
7 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 168
7.1 INTRODUCTION 169
TABLE 129 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 169
7.2 MICROFILTRATION 169
7.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH 169
TABLE 130 GLOBAL MICROFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 170
TABLE 131 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 132 EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 133 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 134 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
7.3 ULTRAFILTRATION 171
7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES TO DRIVE GROWTH 171
TABLE 135 GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 136 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 137 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 138 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 139 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
 
7.4 NANOFILTRATION 174
7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH 174
TABLE 140 GLOBAL NANOFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 174
TABLE 141 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 142 EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 143 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 144 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 176
7.5 OTHER TECHNIQUES 176
TABLE 145 GLOBAL OTHER TECHNIQUES MARKET, BY REGION, 2021–2028 (USD MILLION) 176
TABLE 146 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 147 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 148 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 149 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
8 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION 179
8.1 INTRODUCTION 180
TABLE 150 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
8.2 FINAL PRODUCT PROCESSING 180
TABLE 151 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2021–2028 (USD MILLION) 181
TABLE 152 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 153 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 154 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 155 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 156 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 183
8.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION 183
8.2.1.1 Continuous requirement for API filtration to drive market growth 183
TABLE 157 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 184
TABLE 158 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 159 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 160 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 161 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
8.2.2 PROTEIN PURIFICATION 186
8.2.2.1 Recent advancements in protein therapeutic drugs to propel growth 186
TABLE 162 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 187
TABLE 163 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 164 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 165 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 166 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 189
8.2.3 VACCINE AND ANTIBODY PROCESSING 189
8.2.3.1 Development of vaccines for COVID-19 and other viral diseases to drive growth 189
TABLE 167 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2021–2028 (USD MILLION) 189
TABLE 168 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 169 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 170 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 171 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 191
8.2.4 FORMULATION AND FILLING SOLUTIONS 191
8.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth 191
TABLE 172 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2021–2028 (USD MILLION) 192
TABLE 173 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 174 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 175 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 176 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 194
8.2.5 VIRAL CLEARANCE 194
8.2.5.1 Growing development of therapeutic monoclonal antibodies to drive market 194
TABLE 177 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2021–2028 (USD MILLION) 195
TABLE 178 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 179 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 180 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 181 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 197
8.3 RAW MATERIAL FILTRATION 197
TABLE 182 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2021–2028 (USD MILLION) 197
TABLE 183 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 184 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 185 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 186 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 187 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 199
8.3.1 MEDIA BUFFER FILTRATION 200
8.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 200
TABLE 188 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY REGION, 2021–2028 (USD MILLION) 200
TABLE 189 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 190 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 191 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 192 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 202
8.3.2 PREFILTRATION 203
8.3.2.1 Membrane fouling issues to drive growth 203
TABLE 193 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY REGION, 2021–2028 (USD MILLION) 203
TABLE 194 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 195 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 196 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 197 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 205
8.3.3 BIOBURDEN TESTING 205
8.3.3.1 Strict quality control of biopharmaceuticals to drive growth 205
TABLE 198 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY REGION, 2021–2028 (USD MILLION) 205
TABLE 199 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 200 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 201 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 202 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 207
8.4 CELL SEPARATION 208
8.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET 208
TABLE 203 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2021–2028 (USD MILLION) 208
TABLE 204 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 205 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 206 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 207 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 210
8.5 WATER PURIFICATION 210
8.5.1 GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET 210
TABLE 208 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 210
TABLE 209 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 210 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 211 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 212 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 212
8.6 AIR PURIFICATION 212
8.6.1 INCREASING ADOPTION OF GMP PRACTICES TO DRIVE GROWTH 212
TABLE 213 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 213
TABLE 214 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 215 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 216 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 217 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 215
 
9 PHARMACEUTICAL FILTRATION MARKET, BY TYPE 216
9.1 INTRODUCTION 217
TABLE 218 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
9.2 STERILE FILTRATION 217
9.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 217
TABLE 219 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 218
TABLE 220 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 221 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 222 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219
TABLE 223 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219
9.3 NON-STERILE FILTRATION 219
9.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH 219
TABLE 224 GLOBAL NON-STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 220
TABLE 225 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 226 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 227 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 228 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 222

　

ページTOPに戻る


　

Summary

The pharmaceutical filtration market is expected to grow at a CAGR of 14.2% during the forecast period. The market is estimated to be around USD 13.5 billion in 2023 and is projected to reach USD 26.2 billion by 2028. Growth in the pharmaceutical filtration market can be attributed to factors such as emerging countries like China, India, Brazil, and Mexico offering significant growth opportunities, advancement in nanofiber technology, and increased manufacturing and R&D in the pharmaceutical & biotechnology industries. On the other hand, membrane fouling and the growing capital investment required to set up new production facilities are expected to hinder market growth.
“In 2022 the systems segment accounted for the second largest share of the pharmaceutical market”
Based on products, the pharmaceutical filtration market is segmented into major three segments, namely, filters, systems, and other products. The filter market is further segmented into membrane filters, depth filters, and other filters, such as prefilters, bag filters, and magnetic filters. The systems market is further segmented into single-use systems and reusable systems. In 2022 the systems segment accounted for the second largest share of the pharmaceutical market. The large share of this segment can primarily be attributed rising importance of separation and purification applications. Developments in research techniques and increased demand for more specificity in the filtration process are increasing the adoption of single-use technologies in many small-scale biopharmaceutical processes.
“The ultrafiltration techniques accounted for the second largest market share of this market in 2022”
Based on technique, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The microfiltration techniques accounted for the second largest market share of this market in 2022, and this can be primarily attributed to the implementation of ultrafiltration for cell harvesting and enzyme purification plasma separation. It is also used in the filtration of active pharmaceutical ingredients, media & buffers, formulations, and filling solutions. To a certain extent, UF allows the removal of viruses, phage, colloids, and macromolecules, which cannot be achieved with microfiltration and hence is acquiring large share in the market.
“The sterile filtration technique accounted for the largest market share of this market in 2022”
Based on type, the pharmaceutical filtration market is segmented into sterile filtration and non-sterile filtration. The sterile filtration technique accounted for the largest market share of this market in 2022, and this can be attributed the factors such as the fast growth of biologics, the rapid increase in the requirement of sterile filtration during the liquid processing of biopharmaceuticals, and the benefits of sterile filtration over non-sterile filtration.
Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company, Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), and Membrane Solutions (US) are some of the major players operating in the pharmaceutical filtration market.

“Asia Pacific: The fastest-growing region in the pharmaceutical filtration market”
The pharmaceutical filtration market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the growing incidence rate of viral diseases, the requirement to maintain a clean manufacturing environment because of strict foreign regulatory rules, the fast expansion of generics manufacturing, developments in nanofiber technologies, increasing R&D spending on biopharmaceutical projects, and the growth of the biotechnology industry in developing countries.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side - 20%
• By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%
List of Companies Profiled in the Report:
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Parker-Hannifin Corporation (US)
• Thermo Fisher Scientific Inc. (US)
• 3M Company (US)
• Eaton Corporation plc (US)
• Donaldson Company, Inc. (US)
• Repligen Corporation (US)
• Porvair plc (UK)
• Alfa Laval Corporate AB (Sweden)
• Corning Incorporated (US)
• Meissner Filtration Products, Inc. (US)
• Amazon Filters Ltd. (UK)
• Graver Technologies, LLC (US)
• MMS AG (Switzerland)
• MANN+HUMMEL International GmbH & Co. KG (Germany)
• ErtelAlsop (US)
• Kasag Swiss AG (Switzerland)
• Freudenberg Filtration Technologies SE & Co. KG (Germany)
• Cole-Parmer Instrument Company, LLC. (US)
• Cantel Medical Corp. (US)
• Filtrox AG (Switzerland)
• Saint-Gobain Performance Plastics (France)
• Membrane Solutions (US)
Research Coverage:
This report provides a detailed picture of the pharmaceutical filtration market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 58
1.1 STUDY OBJECTIVES 58
1.2 MARKET DEFINITION 58
1.2.1 INCLUSIONS AND EXCLUSIONS 59
1.3 MARKET SCOPE 60
1.3.1 MARKETS COVERED 60
1.3.2 YEARS CONSIDERED 61
1.4 CURRENCY CONSIDERED 61
1.5 LIMITATIONS 61
1.6 STAKEHOLDERS 62
1.7 SUMMARY OF CHANGES 62
1.7.1 RECESSION IMPACT 63
2 RESEARCH METHODOLOGY 64
2.1 RESEARCH DATA 64
FIGURE 1 RESEARCH DESIGN 64
2.1.1 SECONDARY DATA 65
2.1.2 PRIMARY DATA 66
FIGURE 2 BREAKDOWN OF PRIMARIES, BY RESPONDENT, DESIGNATION, AND REGION 66
2.2 MARKET ESTIMATION METHODOLOGY 67
FIGURE 3 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 67
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 68
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 69
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 69
2.3 MARKET GROWTH RATE PROJECTIONS 70
FIGURE 6 PHARMACEUTICAL FILTRATION MARKET (SUPPLY SIDE): CAGR PROJECTIONS 71
FIGURE 7 PHARMACEUTICAL FILTRATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 72
2.3.1 DATA TRIANGULATION 73
FIGURE 8 DATA TRIANGULATION METHODOLOGY 73
2.4 RESEARCH ASSUMPTIONS 74
2.5 IMPACT OF RECESSION 74
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024−2027 (% GROWTH) 74
2.6 RISK ANALYSIS 75
 
3 EXECUTIVE SUMMARY 76
FIGURE 9 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 76
FIGURE 10 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 77
FIGURE 11 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 77
FIGURE 12 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 78
FIGURE 13 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023 VS. 2028 (USD MILLION) 79
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET 80
4 PREMIUM INSIGHTS 81
4.1 PHARMACEUTICAL FILTRATION MARKET OVERVIEW 81
FIGURE 15 INCREASING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH 81
4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT AND COUNTRY (2022) 82
FIGURE 16 FILTERS SEGMENT TO POSSESS LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL FILTRATION MARKET IN 2022 82
4.3 PHARMACEUTICAL FILTRATION MARKET SHARE, BY APPLICATION (2023 VS. 2028) 82
FIGURE 17 FINAL PRODUCT PROCESSING APPLICATIONS SEGMENT TO DOMINATE MARKET IN 2028 82
4.4 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022 (USD MILLION) 83
FIGURE 18 MICROFILTRATION SEGMENT TO DOMINATE MARKET, BY TECHNIQUE, IN 2022 83
4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 84
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028 84
5 MARKET OVERVIEW 85
5.1 INTRODUCTION 85
5.2 MARKET DYNAMICS 85
FIGURE 20 PHARMACEUTICAL FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 85
TABLE 2 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 86
5.2.1 DRIVERS 87
5.2.1.1 Growing biopharmaceutical industry 87
TABLE 3 INDICATIVE LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS, 2021 AND 2022 87
5.2.1.2 Rising R&D spending in pharmaceutical and biotechnology industries 88
FIGURE 21 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 88
5.2.1.3 Increasing adoption of single-use technologies 88
5.2.1.4 New product launches by leading market players 89
5.2.1.5 Increasing purity requirements in end-user segments 90
5.2.2 RESTRAINTS 90
5.2.2.1 Membrane fouling issues 90
5.2.2.2 Requirement of high capital investments for new production facilities 90
5.2.3 OPPORTUNITIES 91
5.2.3.1 Growth opportunities in emerging economies 91
5.2.3.2 Advances in nanofiber technology 91
5.2.4 CHALLENGES 92
5.2.4.1 Increased cost and reduced speed and yield of filters 92
5.2.4.2 Survival of small players and new entrants 92
5.3 RANGES/SCENARIOS 93
FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PHARMACEUTICAL FILTRATION MARKET 93
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PHARMACEUTICAL FILTRATION PRODUCT PROVIDERS 94
5.5 PRICING ANALYSIS 94
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS 94
TABLE 4 PRICE OF PHARMACEUTICAL FILTRATION PRODUCTS (2022) 94
5.5.2 AVERAGE SELLING PRICE TREND 94
5.6 VALUE CHAIN ANALYSIS 95
FIGURE 24 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET 96
5.7 SUPPLY CHAIN ANALYSIS 96
FIGURE 25 PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS 97
5.8 ECOSYSTEM ANALYSIS 98
FIGURE 26 ECOSYSTEM ANALYSIS: PHARMACEUTICAL FILTRATION MARKET 98
TABLE 5 SUPPLY CHAIN ECOSYSTEM 99
5.9 PATENT ANALYSIS 101
FIGURE 27 PATENT APPLICATIONS FOR PHARMACEUTICAL FILTRATION MARKET, JANUARY 2012–DECEMBER 2022 101
5.10 CASE STUDY ANALYSIS 101
5.10.1 IMPROVED CAPACITY AND EFFICIENCY OF CARBON REMOVAL PROCESS FROM ACTIVE PHARMACEUTICAL INGREDIENTS 101
5.10.2 FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID 102
5.10.3 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS 102
5.10.4 DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS 102
5.10.5 USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS 102
5.11 KEY CONFERENCES AND EVENTS IN 2023 103
TABLE 6 PHARMACEUTICAL FILTRATION MARKET: LIST OF CONFERENCES AND EVENTS 103
5.12 REGULATORY ANALYSIS 104
5.12.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 104
5.12.2 REGULATORY SCENARIO IN DIFFERENT REGIONS/COUNTRIES 105
5.13 PORTER’S FIVE FORCES ANALYSIS 106
TABLE 7 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 106
5.13.1 THREAT OF NEW ENTRANTS 106
5.13.2 THREAT OF SUBSTITUTES 107
5.13.3 BARGAINING POWER OF BUYERS 107
5.13.4 BARGAINING POWER OF SUPPLIERS 107
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 107
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.14.1 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND THEIR INFLUENCE ON BUYING PROCESS 108
FIGURE 28 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL COMPANIES ON BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS 108
5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS AMONG END USERS 108
FIGURE 29 KEY BUYING CRITERIA FOR END USERS 108
6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 109
6.1 INTRODUCTION 110
TABLE 8 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110
6.2 FILTERS 110
TABLE 9 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 10 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 11 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 12 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 13 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 14 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
6.2.1 MEMBRANE FILTERS 113
TABLE 15 GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 16 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 17 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 18 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 19 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 20 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 116
6.2.1.1 Polyethersulfone (PES) 116
TABLE 21 GLOBAL PES MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 22 NORTH AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 23 EUROPE: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 24 ASIA PACIFIC: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 25 LATIN AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.2.1.2 Polyvinylidene difluoride (PVDF) 119
6.2.1.2.1 FDA, USP, and EEC compliance to increase demand for PVDF filters 119
TABLE 26 GLOBAL PVDF MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 27 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 28 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 29 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 30 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
6.2.1.3 Nylon 121
6.2.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth 121
TABLE 31 GLOBAL NYLON MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 32 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 33 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 34 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 35 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.2.1.4 Polytetrafluoroethylene (PTFE) 123
6.2.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 123
TABLE 36 GLOBAL PTFE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 37 NORTH AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 38 EUROPE: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 39 ASIA PACIFIC: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 40 LATIN AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.2.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA) 125
6.2.1.5.1 MCE membranes widely used in analytical and research applications 125
TABLE 41 GLOBAL MCE & CA MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 42 NORTH AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 43 EUROPE: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 44 ASIA PACIFIC: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 45 LATIN AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.2.1.6 Polycarbonate track-etched (PCTE) 128
6.2.1.6.1 PCTE membrane filters widely used in cell biology and analytical testing applications 128
TABLE 46 GLOBAL PCTE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 47 NORTH AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 48 EUROPE: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 49 ASIA PACIFIC: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 50 LATIN AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
6.2.1.7 Other materials 130
TABLE 51 GLOBAL OTHER MATERIAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 52 NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 53 EUROPE: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 54 ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 55 LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
6.2.2 DEPTH FILTERS 133
TABLE 56 GLOBAL DEPTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 57 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 58 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 59 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 60 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 61 DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 135
6.2.2.1 Diatomaceous earth 136
6.2.2.1.1 DE filters used in biotechnology industry for cell clarification 136
TABLE 62 GLOBAL DIATOMACEOUS EARTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 63 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 64 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 65 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 66 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
6.2.2.2 Cellulose 138
6.2.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive growth 138
TABLE 67 GLOBAL CELLULOSE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 68 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 69 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 70 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 71 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
6.2.2.3 Activated carbon 140
6.2.2.3.1 Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations 140
TABLE 72 GLOBAL ACTIVATED CARBON FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 73 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 74 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 75 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 76 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
6.2.2.4 Perlite 143
6.2.2.4.1 Lower density of perlite provides more purity than diatomaceous earth 143
TABLE 77 GLOBAL PERLITE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 78 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 79 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 80 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 81 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
6.2.2.5 Other depth filter media 145
TABLE 82 GLOBAL OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 83 NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 84 EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 85 ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 86 LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
6.2.3 OTHER FILTERS 147
TABLE 87 GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 88 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 89 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 90 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 91 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
6.3 SYSTEMS 150
TABLE 92 GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 93 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 94 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 95 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 96 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 97 GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
6.3.1 SINGLE-USE SYSTEMS 153
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 153
TABLE 98 GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 99 NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 100 EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 101 ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 102 LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
6.3.2 REUSABLE SYSTEMS 155
6.3.2.1 Reusable systems widely used for large-scale manufacturing 155
TABLE 103 GLOBAL REUSABLE SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 155
TABLE 104 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 105 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 106 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 107 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
6.4 OTHER FILTRATION PRODUCTS 157
TABLE 108 OTHER FILTRATION PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 109 NORTH AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 110 EUROPE: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 111 ASIA PACIFIC: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 112 LATIN AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 113 OTHER FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
6.4.1 FILTRATION ASSEMBLIES 160
6.4.1.1 Leading players provide pre-assembled filtration assemblies 160
TABLE 114 GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION, 2021–2028 (USD MILLION) 161
TABLE 115 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 116 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 117 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 118 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
6.4.2 FILTER HOLDERS 163
6.4.2.1 Filter holders provide structural support to membrane filters 163
TABLE 119 GLOBAL FILTER HOLDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 120 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 121 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 122 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 123 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 165
6.4.3 FILTRATION ACCESSORIES 165
6.4.3.1 Increasing adoption of pharmaceutical filtration products to support growth 165
TABLE 124 GLOBAL PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 125 NORTH AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 126 EUROPE: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 127 ASIA PACIFIC: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 128 LATIN AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
7 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 168
7.1 INTRODUCTION 169
TABLE 129 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 169
7.2 MICROFILTRATION 169
7.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH 169
TABLE 130 GLOBAL MICROFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 170
TABLE 131 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 132 EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 133 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 134 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
7.3 ULTRAFILTRATION 171
7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES TO DRIVE GROWTH 171
TABLE 135 GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 136 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 137 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 138 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 139 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
 
7.4 NANOFILTRATION 174
7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH 174
TABLE 140 GLOBAL NANOFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 174
TABLE 141 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 142 EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 143 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 144 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 176
7.5 OTHER TECHNIQUES 176
TABLE 145 GLOBAL OTHER TECHNIQUES MARKET, BY REGION, 2021–2028 (USD MILLION) 176
TABLE 146 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 147 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 148 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 149 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
8 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION 179
8.1 INTRODUCTION 180
TABLE 150 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
8.2 FINAL PRODUCT PROCESSING 180
TABLE 151 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2021–2028 (USD MILLION) 181
TABLE 152 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 153 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 154 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 155 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 156 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 183
8.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION 183
8.2.1.1 Continuous requirement for API filtration to drive market growth 183
TABLE 157 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 184
TABLE 158 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 159 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 160 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 161 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
8.2.2 PROTEIN PURIFICATION 186
8.2.2.1 Recent advancements in protein therapeutic drugs to propel growth 186
TABLE 162 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 187
TABLE 163 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 164 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 165 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 166 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 189
8.2.3 VACCINE AND ANTIBODY PROCESSING 189
8.2.3.1 Development of vaccines for COVID-19 and other viral diseases to drive growth 189
TABLE 167 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2021–2028 (USD MILLION) 189
TABLE 168 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 169 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 170 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 171 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 191
8.2.4 FORMULATION AND FILLING SOLUTIONS 191
8.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth 191
TABLE 172 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2021–2028 (USD MILLION) 192
TABLE 173 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 174 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 175 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 176 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 194
8.2.5 VIRAL CLEARANCE 194
8.2.5.1 Growing development of therapeutic monoclonal antibodies to drive market 194
TABLE 177 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2021–2028 (USD MILLION) 195
TABLE 178 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 179 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 180 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 181 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 197
8.3 RAW MATERIAL FILTRATION 197
TABLE 182 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2021–2028 (USD MILLION) 197
TABLE 183 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 184 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 185 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 186 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 187 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 199
8.3.1 MEDIA BUFFER FILTRATION 200
8.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 200
TABLE 188 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY REGION, 2021–2028 (USD MILLION) 200
TABLE 189 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 190 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 191 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 192 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 202
8.3.2 PREFILTRATION 203
8.3.2.1 Membrane fouling issues to drive growth 203
TABLE 193 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY REGION, 2021–2028 (USD MILLION) 203
TABLE 194 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 195 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 196 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 197 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 205
8.3.3 BIOBURDEN TESTING 205
8.3.3.1 Strict quality control of biopharmaceuticals to drive growth 205
TABLE 198 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY REGION, 2021–2028 (USD MILLION) 205
TABLE 199 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 200 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 201 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 202 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 207
8.4 CELL SEPARATION 208
8.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET 208
TABLE 203 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2021–2028 (USD MILLION) 208
TABLE 204 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 205 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 206 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 207 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 210
8.5 WATER PURIFICATION 210
8.5.1 GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET 210
TABLE 208 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 210
TABLE 209 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 210 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 211 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 212 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 212
8.6 AIR PURIFICATION 212
8.6.1 INCREASING ADOPTION OF GMP PRACTICES TO DRIVE GROWTH 212
TABLE 213 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 213
TABLE 214 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 215 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 216 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 217 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 215
 
9 PHARMACEUTICAL FILTRATION MARKET, BY TYPE 216
9.1 INTRODUCTION 217
TABLE 218 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
9.2 STERILE FILTRATION 217
9.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 217
TABLE 219 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 218
TABLE 220 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 221 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 222 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219
TABLE 223 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219
9.3 NON-STERILE FILTRATION 219
9.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH 219
TABLE 224 GLOBAL NON-STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 220
TABLE 225 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 226 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 227 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 228 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 222

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.